Dynavax Technologies Corp has a consensus price target of $24.25 based on the ratings of 18 analysis. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on June 28, 2024, May 14, 2024, and May 9, 2024, respectively. With an average price target of $29 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 157.78% upside for Dynavax Technologies Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/28/2024 | Buy Now | 157.78% | HC Wainwright & Co. | Edward White | $29 → $29 | Reiterates | Buy → Buy | Get Alert |
05/14/2024 | Buy Now | 157.78% | HC Wainwright & Co. | Edward White | → $29 | Reiterates | Buy → Buy | Get Alert |
05/09/2024 | Buy Now | 157.78% | HC Wainwright & Co. | Edward White | → $29 | Reiterates | Buy → Buy | Get Alert |
02/01/2024 | Buy Now | 77.78% | Goldman Sachs | Paul Choi | → $20 | Initiates | → Neutral | Get Alert |
11/03/2023 | Buy Now | 140% | JMP Securities | Roy Buchanan | $25 → $27 | Maintains | Market Outperform | Get Alert |
11/03/2023 | Buy Now | 148.89% | HC Wainwright & Co. | Edward White | $27 → $28 | Maintains | Buy | Get Alert |
08/04/2023 | Buy Now | 140% | HC Wainwright & Co. | Edward White | → $27 | Reiterates | Buy → Buy | Get Alert |
08/04/2023 | Buy Now | 122.22% | JMP Securities | Roy Buchanan | $24 → $25 | Maintains | Outperform | Get Alert |
05/03/2023 | Buy Now | 113.33% | JMP Securities | Roy Buchanan | $25 → $24 | Maintains | Outperform | Get Alert |
05/03/2023 | Buy Now | 140% | HC Wainwright & Co. | Edward White | → $27 | Reiterates | → Buy | Get Alert |
02/24/2023 | Buy Now | 122.22% | JMP Securities | Roy Buchanan | $22 → $25 | Maintains | Market Outperform | Get Alert |
02/24/2023 | Buy Now | 140% | HC Wainwright & Co. | Edward White | $28 → $27 | Maintains | Buy | Get Alert |
11/04/2022 | Buy Now | 86.67% | Goldman Sachs | Madhu Kumar | $24 → $21 | Maintains | Buy | Get Alert |
09/27/2022 | Buy Now | 95.56% | JMP Securities | Roy Buchanan | → $22 | Initiates | → Market Outperform | Get Alert |
12/29/2021 | Buy Now | 148.89% | HC Wainwright & Co. | Edward White | $23 → $28 | Maintains | Buy | Get Alert |
08/31/2021 | Buy Now | 104.44% | HC Wainwright & Co. | Edward White | — | Maintains | Buy | Get Alert |
08/06/2021 | Buy Now | 68.89% | Goldman Sachs | Madhu Kumar | — | Initiates | → Buy | Get Alert |
08/05/2021 | Buy Now | 77.78% | HC Wainwright & Co. | Edward White | — | Maintains | Buy | Get Alert |
The latest price target for Dynavax Technologies (NASDAQ:DVAX) was reported by HC Wainwright & Co. on June 28, 2024. The analyst firm set a price target for $29.00 expecting DVAX to rise to within 12 months (a possible 157.78% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Dynavax Technologies (NASDAQ:DVAX) was provided by HC Wainwright & Co., and Dynavax Technologies reiterated their buy rating.
There is no last upgrade for Dynavax Technologies
There is no last downgrade for Dynavax Technologies.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Dynavax Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Dynavax Technologies was filed on June 28, 2024 so you should expect the next rating to be made available sometime around June 28, 2025.
While ratings are subjective and will change, the latest Dynavax Technologies (DVAX) rating was a reiterated with a price target of $29.00 to $29.00. The current price Dynavax Technologies (DVAX) is trading at is $11.25, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.